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bioassay-guided fractionation and molecular networking techniques. The results led to the identification 
of seventeen compounds, one of them was a fatty acid derivative, two compounds had flavonoid 
structure and others were furanocoumarin type compounds. In vitro analysis showed that the subfraction 
F10fwas the most potent inhibitor against the activity of AChE with an IC50value of 25.2 μg/mL and good 
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Graphical abstract 
Acetylcholinestrase-inhibitory activity of Iranian plants: Combined HPLC/bioassay-guided 
fractionation, molecular networking and docking strategies for the dereplication of active 
compounds 
 
 
 
Highlights 
Prangos ferulacea was the most active plant against the acetylcholinesterase enzyme. 
Metabolites were analyzed by bioassay-guided fractionation and molecular networking. 
Phytochemical analysis of the active extract led to the identification of 17 compounds. 
Flavonoids showed a high affinity to the enzyme based on docking score values. 
 
 
 Abstract 
In order to search for discovery of acetylcholinesterase (AChE) inhibitors, as a therapeutic strategy 
for treatment of the Alzheimer’s disease, twenty-five Iranian plants have been evaluated by an in 
vitro enzymatic Ellman method and molecular docking study. Each plant was successively 
extracted by n-hexane, ethyl acetate and methanol to obtain a total of 75 extracts. The inhibiting 
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effect of extracts was measured by a colorimetric assay in 96-well microplates. The n-hexane 
extract of Prangos ferulacea showed the highest AChE inhibitory activity with 75.6% inhibition 
at a concentration of 50 µg/mL. The chemical composition of this extract was investigated in detail 
based on a combination of HPLC/bioassay-guided fractionation and molecular networking 
techniques. The results led to the identification of seventeen compounds, one of them was a fatty 
acid derivative, two compounds had flavonoid structure and others were furanocoumarin type 
compounds. In vitro analysis showed that the subfraction F10f was the most potent inhibitor against 
the activity of AChE with an IC50 value of 25.2 µg/mL and good docking scores of its constituents 
confirming its high activity. 
 
Keywords 
Acetylcholinesterase inhibitors, Ellman assay, Molecular networking, HPLC-ESI-QToF-MS/MS, 
Molecular docking, Prangos ferulacea 
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1. Introduction 
Dementia is one of the biggest global public health challenges facing our generation because of 
increasing elderly population in different countries. Dementia is a syndrome that can be caused by 
a number of progressive disorders that affect memory, thinking, behavior and the ability to perform 
everyday activities [1]. Alzheimer’s disease is the most common type of dementia, which is 
characterized by a loss or decline of memory, difficulties with language and problem-solving and 
other behavioral abnormalities in the patient, mostly due to a deficit of cholinergic functions in the 
brain. Alzheimer’s disease (AD) occurs in ≥40% of people over the age of 85. Alzheimer’s Disease 
International estimated there were about 47 million people living with dementia worldwide in 2016 
and this number is expected to increase to more than 131 million by 2050 [2]. Alzheimer is a 
multifactorial disease and therefore demands multiple therapeutic approaches. One of the most 
important therapeutic strategies is controlling the level of acetylcholine (ACh), as a 
neurotransmitter in cholinergic synapses, through blocking the degradation of ACh using 
acetylcholinesterase inhibitors (AChEIs) [3]. Acetylcholinestrase acts as a key enzyme for 
hydrolyzing acetylcholine into choline and acetic acid. A few AChE inhibitors such as tacrine, 
galantamine, donepezil and rivastigmine have been used for treatment of Alzheimer’s disease [4]. 
The search for new AChE inhibitors is of great interest.  
Medicinal plants are rich resources of different bioactive constituents that can be used for the 
treatment of several diseases and inhibition of various enzymes. Therefore, the empirical approach 
to discover new drugs from the systematic screening of plant extracts or plant-derived substances 
coupled with ethnopharmacological knowledge still remains an important strategy for finding new 
lead compounds. One of the major challenges in natural products drug discovery is the selective 
isolation and identification of valuable lead compounds from a complex crude extract. HPLC-
based activity profiling has been used successfully for the rapid localization and characterization 
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of bioactive natural products (NPs) in extracts [5, 6]. Dereplication, using computational 
techniques for the rapid identification of known compounds, is another important approach aspect 
of drug discovery and metabolomics [7, 8]. Current dereplication strategies include hyphenated 
techniques such as HPLC-NMR, HPLC-MS, HPLC-NMR-MS and HPLC-MS/MS [9, 10]. 
Molecular networking (MN), as one of the most widely used dereplication procedures, is a strategy 
that aids rapid identification of known metabolites in complex biological matrices using MS and 
MS/MS analyses. High-resolution MS data provide the precursor ion of constituents which when 
combined with MS/MS data can further aid dereplication of secondary metabolites in natural 
products by acquiring highly resolved and accurate MS/MS spectra. Since the MS/MS spectra are 
linked to the chemical structure of the fragmented metabolites, MN is able to group molecules 
according to their structural similarities. The use of MS/MS data to build molecular networks can 
identify compounds that are structurally related but requires MS/MS data in integrated compound 
databases for their identification [11]. There are different free web-based databases available 
including the Human Metabolome Database (HMDB) [12], LipidMaps [13], MassBank [14], 
National Institute of Standards and Technology (NIST) [15] and other databases that have been 
used for dereplication of natural products. The Global Natural Products Social (GNPS) Molecular 
Networking website includes a suite of libraries containing a large number of MS/MS spectra of 
known natural products for the purpose of dereplication [16]. 
To date, numerous plant extracts world-wide have been evaluated for AChEI activity [17, 18], but 
most Iranian species have not been studied from this aspect. Thus, to discover new herbal 
compounds with an AChE inhibitory effect, this study focused on the screening of 25 Iranian plants 
by the spectrophotometric method of Ellman on an ELISA microplate reader [19] coupled with 
bioassay-guided fractionation and molecular networking analysis of the most effective extracts. 
Some of these plants are used for food and fodder and they have also been used in Iranian 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
traditional herbal medicine for the treatment of different diseases. Alhagi mannifera (Taranjebin; 
family fabaceae) has been used in Iranian folk medicine as a laxative, antipyretic and expectorant 
and to treat hyperbilirubinemia [20, 21]. Fresh or dried leaves of Chaerophyllum macrospermum 
and Kelussia odoratissima (both family apiaceae) are used as a flavoring in soups and foods. 
Eupatorium cannabinum (family asteraceae), Glaucium fimbrilligerum and Papaver commutatum 
(both in family papaveraceae) have also been used as sedatives, antitussives, analgesics, hypnotics, 
anticough and remedies for treatment of liver diseases. They contain many biological active 
constituents such as alkaloids and flavonoids which can be used for treatment of Alzheimer disease 
[22]. Prangos ferulacea, belonging to the Apiaceae or Umbelliferae family, is traditionally used 
as a laxative and against ruminant parasites and neurological difficulties and as a flavoring additive 
in yogurt [23]. It is widely used as an animal fodder because of its valuable nutritive properties 
[22]. Literature review revealed that a number of coumarin and furanocoumarin derivatives have 
been reported from this species [23]. Herein, we report the AChE inhibition activity of different 
plant extracts and the isolation of the active compounds from the most effective extract. Also, we 
generated a network of MS/MS data from three active subfractions of the n-hexane extract of P. 
ferulaceae to demonstrate how molecular networking can be used to dereplicate known 
compounds and identify close analogues. Furthermore, we have studied the key binding 
interactions between the most active identified compound and its AChE inhibitory activity through 
docking analysis.  
2. Experimental 
2.1 General experimental procedures 
NMR spectra were recorded on a Bruker AVANCE III spectrometer operating at 500.13 MHz for 
1H NMR and 125.77 MHz for 13C NMR. A 1 mm TXI microprobe with a z-gradient was used for 
1H-detected experiments. HPLC Bioassay-guided fractionation was done using a Knauer HPLC 
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system by SunFire C18 column (250 mm × 4.6 mm) and Knauer photodiode array detector (PDA). 
The absorbance values were determined with a multi-well plate spectrophotometer (Elx 800 
Microplate Reader, Bio-TEK, Winooski, Vermont, USA) at 570 nm. UHPLC-MS analyses were 
performed on a Waters Acquity UPLC system coupled to a Waters XevoTM quadrupole time-of-
flight (QToF) mass spectrometer and equipped with an electrospray source with lockspray 
interface for accurate mass measurements. Acetylcholinesterase enzyme (AChE) from bovine 
erythrocyte, acetylthiocholine iodide (ATCI) and 5,5-dithiobis-(2-nitrobenzoic acid) (DTNB)  
were  obtained  from  Sigma. Silica gel (70–230 mesh) was used for column chromatography, and 
precoated silica gel F254 (20×20 cm) plates for TLC (both from Merck). 
2.2 Plant material 
Twenty-five different Iranian plants were collected from various regions of Iran and identified by 
Dr. Ali Sonboli. The voucher specimens have been preserved in the herbarium of the Medicinal 
Plants and Drugs Research Institute (MPDRI) of Shahid Beheshti University, Tehran, Iran (Table 
1). 
2.3 Extraction 
The aerial parts of plants were dried at room temperature and ground into a fine powder in a 
mechanical grinder. A 20 g portion of each plant was weighed accurately in a digital balance and 
successively extracted with n-hexane, ethyl acetate and methanol using a maceration method at 
room temperature (3 × 200 mL). The extracts of each solvent were combined and evaporated to 
dryness under reduced pressure at 45°C to obtain solventless n-hexane, ethyl acetate and methanol 
extracts and further used in an Ellman assay.  
2.4 Determination of AChE inhibitory activity 
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The AChE activity of the extracts and purified compounds and also HPLC-based activity profiling 
were measured according to the method developed by Ellman et al. with some modifications [19]. 
In this method, AChE hydrolyzes the substrate acetylthiocholine iodide (ATCI) to produce 
thiocholine. The reaction between 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) and thiocholine 
causes the formation of the yellow 5-thio-2-nitrobenzoate anion, which can be detected at 405 nm. 
Crude extracts were prepared in two concentrations of 50 and 200 µg/mL. Concentration of the 
microfractions of the n-hexane extract of P. ferulacea for determination of its activity profile was 
20 µg/mL. The purified compounds were also tested at concentrations ranged from 10-200 µg/mL. 
All samples were dissolved in DMSO and then diluted with buffer A (50 mM Tris‐HCl, pH 7.9 
containing 0.1 M NaCl and 0.02 M MgCl2.6H2O) to give solutions with 10% of DMSO. In brief, 
25 μL of 15 mM ATCI in water, 125 μL of 3 mM DTNB in buffer A, 50 μL of buffer B (50 mM 
Tris‐HCl, pH 7.9) and 25 μL of sample were mixed together in a 96‐well plate and the absorbance 
was measured at 405 nm five times every 15 s. The enzymatic reaction was initiated by addition 
of 25 μL of AChE (0.22 U/mL in buffer B) and the plate was incubated at 25 °C for 10 min. Then 
the absorbance was measured again eight times every 15 s. The final DMSO concentration was 
1% in each well. Each assay was done in triplicate. Galantamine was used as a positive control. 
The percent inhibition of AChE was determined by comparison of rates of reaction of samples 
relative to blank sample (5% DMSO in buffer A) using the formula (E - S)/E × 100, where E is 
the activity of enzyme without test sample and S is the activity of the enzyme with the test sample. 
To avoid any increase in activity due to the extracts or spontaneous hydrolysis of substrate, the 
rate of reaction before addition of the enzyme was subtracted from the rate of reaction after adding 
the enzyme. 
2.5 HPLC bioassay-guided fractionation 
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Selected extract was injected into the analytical HPLC system for activity profiling. An aliquot of 
600 µg of the n-hexane extract of Prangos ferulacea was separated on a SunFire C18 column (3.5 
µm, 10 × 150 mm; Waters) with water (solvent A) and acetonitrile (solvent B) using the following 
gradient: 45% B to 100% B in 20 minutes, hold for 5 min and then changed to 45% B and hold 
again for 4 minutes. The flow rate was 0.5 ml/min. Twenty-five one-minute fractions were 
collected into 96 deep well plates and dried using a nitrogen evaporator device (Ultravap, Porvair) 
at 40°C and submitted to bioassay. Typical evaporation time was 2 h. The dried microfractions 
were dissolved in 5 µL of DMSO and then diluted with 95 µL of water. This gave the stock 
solutions which could be used for the assays. 
2.6 Extraction and isolation 
The dried aerial parts of Prangos ferulacea (250 g) were powdered and extracted at room 
temperature with n-hexane (3 × 2L) for two days each. The extracts were concentrated under 
reduced pressure to afford 4.5 g of n-hexane extract. This extract was fractionated by open column 
chromatography (63–200 µm, 3.5 × 50 cm, 300 g silica gel) eluting as a gradient from 100% n-
hexane to 100% EtOAc and then followed by increasing concentrations of MeOH (up to 50%) in 
EtOAc. The flow rate was approximately 15 mL/min. The effluents were combined to give 12 
fractions (1–12) based on TLC patterns (bands were detected on TLC under UV or by heating after 
spraying with 5% phosphomolybdic acid in EtOH). Fractions were also monitored by HPLC-PDA 
analysis and compared with the activity profile in order to localize the bioactive compounds. They 
were found in F4, F5, F8 and F10 fractions. Fraction 4 [0.8 g, eluted with n-hexane-EtOAc (80 : 20)] 
was subjected to silica gel column chromatography (63-200 µm, 1.5 × 50 cm) and eluted with 
CHCl3-EtOAC [(90 : 10), 3.0 L] to afford five subfractions (F4a–F4e). Subfraction F4c was 
recrystallized from ethyl acetate to afford compound 1 (imperatorin) [24]. Subfraction F4b was 
further separated on silica gel preparative TLC to give compound 5 [2-(4-hydroxyphenyl) ethyl 
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triacontanoate, 5] [25]. From fraction 7 [0.4 g, eluted with n-hexane−EtOAc (70:30)] crude solid 
was obtained, which was triturated with acetone to afford compound 2 (heraclenin) [26]. Fraction 
8 [0.35 g, eluted with n-hexane-EtOAc (35:65)] was separated by silica gel column 
chromatography (63-200 µm, 1.5 × 50 cm) and dichloromethane-acetone (90:10) as the mobile 
phase to afford compound 3 (sprengelianin) [27]. Fraction 10 [0.4 g, eluted with EtOAc-MeOH 
(95:5)] was subjected to another silica gel CC (63-200 µm, 2 × 40 cm) eluted with chloroform-
acetone [95:5, 0.5 L; 90:10, 1 L] to give eight subfractions, of which subfraction F10f was further 
recrystallized to afford compound 4 (oxypeucedanin) [28]. Subfraction F10b was an orange solid, 
which after trituration with acetone and methanol was deduced to be as same as compound 2 but 
some minor compounds were observed on its TLC and HPLC analyses. Also, NMR spectra of 
compounds 3 and 4 showed some signals that were not in relation to the major identified 
compounds. Further, HPLC analyses confirmed the presence of compounds with low amount 
beside major identified compounds. Due to the high activity of mentioned fractions, identification 
of their constituents was the interest of this research to discover the effective chemical compounds 
against the AChE enzyme. The isolation of minor compounds was not possible by 
chromatographic methods because of the low amount of the fractions. So, a molecular networking 
method was performed on fraction 8 (F8) and subfractions F10b and F10f to completely identify their 
constituents. 
2.7 Mass spectrometry analysis 
Chromatography was performed on a Waters Acquity UPLC system coupled to a Waters XevoTM 
quadrupole time-of-flight (QToF) mass spectrometer and equipped with a Z-spray electrospray 
ionisation (ESI) source with lockspray interface for accurate mass measurements. ESI MS data 
were acquired in positive ion mode over the 100-1000 m/z range using a survey scan method with 
lock correction allowing simultaneous acquisition of MS and MS/MS data for each sample. A 
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leucine enkephalin (0.4 µg/ml solution in 50% acetonitrile with 0.1 % formic acid) showing ions 
at m/z 278.1134 and 556.2771 in positive mode was used for lock mass correction. Samples were 
prepared in methanol at 2 mg/ml and typically 5 µl were injected for each LC-MS analysis. A 5 
µm SunFireTM C-18 column (250 ×4.6 mm) was maintained at 25ºC and eluted at a flow rate of 
0.4 mL/min with water + 0.1% acetic acid (solvent A) and methanol + 0.1% acetic acid (solvent 
B). Fraction F8 was eluted using the following gradient: 0-5 min, 70% B; 5-10 min, to 75% B, 10-
15 min, 75% B; 15-25 min, to 100% B; 25-35 min, 100% B; 35-36 min, to 70% B (return to initial 
conditions) and 36-40 min, 70% B. subfractions F10b was eluted by the following gradient: 0-30 
min, from 70% to 100% B; 30-35 min, 100% B; 35-36 min, to 70% B (return to initial conditions) 
and 36-40 min, 70% B. The gradient of: 0-20 min, 50% B; 20-30 min, to 100% B; 30-37 min, 
100% B; 37-38 min, to 50% B (return to initial conditions) and 38-43 min, 50% B was used to 
elute subfraction F10f. Spectra were acquired using a capillary voltage of 3.0 kV, a detector voltage 
of 2.2 kV and a sampling cone and extraction cone voltages of 25 V and 4.0V, respectively. The 
source and desolvation temperatures were set at 150oC and 250oC, respectively, with a cone and 
desolvation flow of 50 L/h and 600 L/h, respectively. MS/MS survey scans were set up as data 
dependent acquisition where the 8 most intense ions detected in the MS spectrum were selected as 
MS/MS precursors. Typically, the threshold for MS/MS targeting was set to 50 with targeted ions 
subsequently excluded from targeting for 15 seconds.  MS/MS scans were obtained for selected 
ions with CID fragmentation, isolation width of 2.0, normalized collision energy of 36 V, 
activation Q of 0.250, and activation time of 30 ms. 
2.8 Molecular networking 
Molecular networks were created using the online work flow at the GNPS website 
(http://gnps.ucsd.edu). The data were clustered with MS-Cluster with a parent mass tolerance of 
0.2 Da and a MS/MS fragment ion tolerance of 0.08 Da to create molecular networks where each 
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node is a consensus MS/MS spectrum and edges between the nodes indicate the degree of 
similarity between consensus spectra. A network was created in which edges were filtered to have 
a cosine score above 0.65 and more than five matched peaks. The spectra in the network were then 
searched against GNPS’s spectral libraries. The data visualization of molecular families was 
performed on Cytoscape 2.8.3 using the Spring Embedded layout plug-in and displayed as a 
network of nodes and edges. In Cytoscape, attributes of molecular networks are tuned to help data 
interpretation such as edge thickness, which can be proportional to the cosine score, node size, 
which can be correlated to precursor ion intensity and or node color, which can be used to map 
various metadata associated with samples (group mapping). 
2.9 Molecular docking study 
The molecular docking study was carried out using the Glide application in the Schrodinger 
package 2016-2 (Schrodinger, LLC). The acetylcholinestrase enzyme protein structure file (PDB 
ID: 1EVE) was taken from PDB and was edited using protein preparation on Maestro 10.6, where 
all water molecules and co-crystallized ligands were removed. Partial atomic charges were 
assigned according to the optimized potentials for the liquid simulations (OPLS3) force field. The 
grid box was centered at particular residues of the protein and was generated with the Grid 
generation application with coordinates x = 2.023, y = 63.295, z = 67.062. The dimensions of the 
active site box were set at 40 × 40 × 40 × A [29]. The structures were then subjected to impact 
minimization with a cut off RMSD of 0.3 Å. The Ligand Preparation module (LigPrep) in Maestro 
was used to prepare the ligands in this study. The 2D structures of the desired compounds were 
drawn on ChemDraw Professional 15.0 and 3D structures generated using Chem3D suite. The 
structures were saved in SDF format and prepared for docking. The drawn ligands were geometry 
optimized using the OPLS3 force field. Docking was carried out using Glide-5.5. Flexible ligand 
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docking was accomplished for all of the compounds (1-17). Galantamine was used as the positive 
control. 
3. Results and discussion 
3.1 Screening 
Twenty-five Iranian medicinal plant materials were collected and extracted with different organic 
solvents (including n-hexane, ethyl acetate and methanol) to yield seventy-five extracts. The 
inhibitory activity of these extracts was evaluated in vitro against the AChE enzyme at two 
concentrations of 50 and 200 µg/mL. As shown in Table 1, the highest AChE inhibitory activity 
was observed for the n-hexane extract of Prangos ferulacea with 75.6% inhibition at a 
concentration of 50 µg/mL, followed by the EtOAc extract of Prangos ferulacea, the n-hexane 
extract of Hedysarum atropatanum, the EtOAc extract of Glaucium fimbrilligerum and the EtOAc 
extract of Plumbago europaea, which showed inhibition values of 63.8, 60.9, 61.1 and 58.0%, 
respectively. The lack of reported AChE inhibitory activity of constituents of P. ferulaceae made 
this plant species particularly interesting, so it was further subjected to HPLC-based activity 
profiling with the n-hexane extract of Prangos ferulacea as the most active extract against AChE 
enzyme. 
3.2 Isolation and identification of active compounds 
P. feruaceae gave the highest AChE inhibitory activity of its n-hexane extract and was investigated 
in detail. A bioassay-guided fractionation method was performed to identify the bioactive 
components of the plant extract using a previously validated protocol [30]. In brief, 600 µg of 
extract was separated on an analytical C18 column. The column effluent was collected into a 96 
well plate every minute to obtain twenty-five subfractions. They were dried and re-dissolved in a 
small amount of 10% DMSO in buffer A. Then, the activity profile was confined based on a 
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bioactivity test that showed the zones of activity of the extract were concentrated at three different 
time windows including Rt1 2.5-4 min, Rt2 6-8 min and Rt3 12-13 min, of which the second time 
window contained the most dominant peaks in the chromatogram. Fig. 1 indicates the HPLC 
chromatogram and the activity profiling of the time-based microfractions.  
For the isolation of targeted compounds, extraction of the plant was performed on a larger scale 
(250 g of dried plant) and subjected to column chromatography to give twelve combined fractions 
with the aid of TLC analysis. To ensure the effective isolation of the most potent compounds, 
fractions were analyzed by HPLC-PDA and TLC to match fractions containing targeted 
compounds with the profile of activity. Fractions F2, F7, F8 and F10 were purified by column 
chromatography and preparative TLC and characterized with the aid of NMR spectroscopy and 
molecular networking to afford fourteen known furanocoumarin compounds, two flavonoids and 
one fatty acid derivative.  
Structures of compounds 1-5 were elucidated by 1D and 2D NMR analyses (COSY, HSQC-DEPT 
and HMBC) and confirmed by comparing their NMR data with those reported in the literature. 
The structures were determined to be imperatorin (1) [24], heraclenine (2) [26], sprengelianin (3) 
[27], oxypeucedanin (4) [28] and 2-(4-hydroxyphenyl) ethyl triacontanoate (5) [25]. A molecular 
networking technique was used to deduce the structures of compounds 6-17 as well as some 
identified compounds by NMR with the use of HRMS and MS/MS data and comparison with 
databases. Global Natural Products Social (GNPS) has collected available MS/MS spectral 
libraries of a large number of known natural products including those from MassBank [14], NIST 
[15] and ReSpect [31]. Altogether, these third-party libraries total 212,230 MS/MS spectra 
representing 12,694 unique compounds. The molecular network was generated from direct 
injection of the subfractions F10b, F10f and F8 which each subfraction collection and also their 
overlapping are represented by nodes in different colors (Fig. 2). Every node is indicating a 
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particular ion detected by MS and the edges are representing the relationship between different 
nodes, with thicker lines between two particular ions representing more relationship and vice versa. 
Then, nodes of the network were dereplicated in an automated batch mode against the GNPS 
databases, which led to the identification of fifteen constituents including three isolated 
compounds heraclenine (2), sprengelianin (3), oxypeucedanin (4) as well as methoxsalen (6), 
oroselol (7), isopimpinellin (8), marmesin (9), phellopterin (10), heraclenol (11), oxypeucedanin 
hydrate (12), [3-hydroxy-2-methyl-4-(7-oxofuro[3,2g]chromen-9-yl) oxybutan-2-yl] (Z)-2-
methylbut-2-enoate (13), 8-[2-(3-methylbutyroxy)-3-hydroxyl-3-methylbutoxylpsoralen (14), 
rivulobirin A (15), quercetin (16) and querciturone (17). MS/MS fragmentation patterns of all 
identified compounds were annotated to verify that the fragmentation patterns were related 
(supporting Information, S1-S15).  
Except compounds 16 and 17 which have a flavonoid structure, all other compounds are 
furanocoumarins that have previously been reported from several different species of the Prangos 
genus [32-34]. Individual identified compounds of each fraction were recognized with more 
investigation of molecular network. The constituents of subfraction F10b were compounds 2, 3, 6, 
8, 9, 11, 13 and 14 of which, compounds 2, 3, 8 and 9 were also found in F8. Compounds 4, 7, 10, 
12, 15, 16 and 17 included the chemical compounds of subfraction F10f. Heraclenine (2), 
sprengelianin (3) and oxypeucedanin (4) which were the major compounds of the analyzed 
fractions previously isolated and identified by NMR data provide confirmation between the results 
of the molecular networking technique and identification of compounds by purification and 
structural analysis. Chemical structures of the isolated compounds and also of the identified 
compounds from molecular networking are shown in Fig. 3. A review of the literature showed that 
all of the pure compounds are reported for the first time from P. ferulacea. 
3.3 Anticholinesterase inhibitory activity 
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During this study, the isolated compounds (1, 2 and 5) and concentrated subfractions (F10b, F10f 
and F8) were screened for their in vitro AChE inhibitory activity at different concentrations using 
a 96-well microplate reader according to the method developed by Ellman. These compounds 
inhibited AChE activity in a dose dependent manner. As presented in Table 2, F10f was found to 
be the most potent inhibitor against AChE with an IC50 value of 25.2 µg/mL, followed by F10b 
(34.9 µg/mL) and F8 (38.2 µg/mL). IC50 values of 65.1, 56.8 and 130.3 µg/mL were recorded for 
compounds 1, 2 and 5, respectively. In this study, galantamine was used as the positive control, 
which had an IC50 value of 1.4 µg/mL.  
3.4 Molecular docking 
All 17 of the identified compounds were docked into the active site of acetylcholinesterase enzyme 
(PDB code: 1EVE) by employing the Glide module (Schrodinger suite). In silico studies revealed 
the affinity, activity and binding orientation of ligands to the target protein 1EVE. The study 
showed that the inhibitory activity of compounds with free hydroxyl groups was better than others. 
Docking results of ligands are shown in Table 3, while interactions between the most active 
compound (17) and the enzyme are shown in Fig. 4. It is clear that there are two important types 
of interactions with the active site of enzyme including H-bond and π-π stacking interactions with 
the G score value of -10.901 kJ/mol. It is shown that the hydroxyl groups of querciturone (17) are 
linked to the active site through five H-bond interactions with TYR70, ASP72, PHE288, ARG289 
and TYR334 amino acids. Also, PHE290 is responsible for the π-π interaction of 17 with the 
enzyme. Among furanocoumarins, compound 15 was the best inhibitor with docking score of -
10.40 kJ/mol due to H-bond and π-π stacking interactions of the ligand with ARG289 and TYR121 
of the enzyme, respectively. Comparing the results of in vitro and in silico analyses indicated that 
subfraction F10f had the best inhibitory activity on AChE, which could be due to the presence of 
some active compounds such as querciturone (17), heraclenol (11) and rivulobirin A (15). 
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The anti-AChE activity of flavonoids [35, 36] as well as furanocoumarins [37, 38] has previously 
been performed by Ellman method and reported in the literature supporting our results. Many MD 
analyses have also been performed to evaluate the interaction of different naturally occurring 
ligands such as flavonoids [7] and furanocoumarins [39] with the AChE enzyme. 
4. Conclusion 
In this study, the AChE inhibitory activity of twenty-five Iranian plants has been evaluated by the 
Ellman method. Four furanocoumarin type compounds and one fatty acid derivative were obtained 
from phytochemical analysis of the n-hexane extract of P. ferulacea, as the most active extract. A 
molecular networking technique was then used to clarify the unidentified compounds of the active 
subfractions, which led to the identification of a further fourteen furanocoumarins and two 
flavonoids. Molecular docking analysis of all 17 compounds was also performed on an AChE 
target with in silico results in good agreement with experimental results. Based on in vitro analysis, 
subfraction F10f was the most potent inhibitor against the activity of AChE with an IC50 value of 
25.2 µg/mL, with strong docking scores further confirming its activity. These results propose that 
the n-hexane extract of P. ferulacea could be considered as AChE inhibitor due to presence of 
biologically active constituents including flavonoids and furanocoumarins. Further studies such as 
in vitro and in vivo analyses are suggested to evaluate the AChE inhibitory activity of the active 
compounds querciturone (17), heraclenol (11) and rivulobirin A (15).  
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Legends for Figures  
Fig. 1 HPLC-based activity profile of the one-minute microfractions of the n-hexane extract of P. 
ferulaceae. Colored rectangles represent three retention time groups indicating more than 40% 
inhibition of AChE activity. The selected extract was fractionated on a SunFire C18 column (3.5 
µm, 10 × 150 mm; Waters) with water (solvent A) and acetonitrile (solvent B) using the following 
gradient: 45% B to 100% B in 20 minutes, hold for 5 min and then changed to 45% B and hold 
again for 4 minutes. The flow rate was 0.5 ml/min. 
Fig. 2 The molecular network of P. ferulaceae subfractions with a cosine similarity score cut off 
of 0.65. In the network, each collection is represented by different colors. The pink, red and green 
circles are representing of F10b, F10f and F8 nodes, respectively. Overlapping nodes are indicated 
by gray circles.  
Fig. 3 Chemical structure of the identified compounds in the active subfractions of the n-hexane 
extract of P. ferulacea. 
Fig. 4 Docked molecule of querciturone (17) in the active site of AChE (PDB code: 1EVE). The 
principal amino acids are evident as the vicinity of the docked molecule. 
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Table 1. AChE inhibitory activity of the n-hexane, ethyl acetate and methanol extracts of the studied Iranian plants 
Percent of inhibition (%) a Voucher 
number 
Collection 
area 
Species No. 
Conc. = 200 µg/mL Conc. = 50 µg/mL 
Methanol EtOAc n-Hexane Methanol EtOAc n-Hexane   
35.1 ± 0.4  58.6 ± 0.7  54.3 ± 1.4  21.8 ± 1.5  30.1 ± 0.5  20.5 ± 2.3 MPH-2531 Tochal Alhagi mannifera 1 
59.3 ± 1.2 65.6 ± 0.5 71.2 ± 0.8 30.0 ± 0.8 34.2 ± 1.3 40.8 ± 1.1 MPH-2532 Darake Alkana trichophyla 2 
59.2 ± 0.4 48.0 ± 0.9 38.9 ± 2.6 24.7 ± 0.4 22.0 ± 0.8 15.1 ± 1.6 MPH-2533 Sis Cerinthe minor 3 
60.9 ± 1.3 52.1 ± 1.2 66.3 ± 3.1 36.3 ± 1.5 31.7 ± 0.6 39.4 ± 0.8 MPH-2534 Tochal Chaerophyllum macrospermum 4 
55.1 ± 2.4 61.3 ± 1.1 35.0 ± 1.4 28.9 ± 1.2 36.3 ± 1.4 12.1 ± 0.7 MPH-2535 Sis Dactylorhiza iberica 5 
68.8 ± 0.6 75.8 ± 0.8 68.6 ± 1.7 45.3 ± 2.3 36.7 ± 0.9  34.3 ± 1.6 MPH-2536 Darake Eupatorium cannabinum 6 
76.3 ± 1.8 84.2 ± 1.3 64.2 ± 0.9 57.1 ± 1.6 61.1 ± 0.5 31.7 ± 3.0 MPH-2537 Taleghan Glaucium fimbrilligerum 7 
75.1 ± 0.8 81.1 ± 1.6 85.1 ± 2.3 52.0 ± 0.5 49.4 ± 1.7 60.9 ± 1.3 MPH-2538 Sis Hedysarum atropatanum 8 
60.4 ± 0.5 64.2 ± 0.8 75.3 ± 1.4 30.3 ± 1.7 27.2 ± 0.7 33.2 ± 1.8 MPH-2539 Velenjak Heliotropium europaeum 9 
81.2 ± 1.9 66.7 ± 0.4 71.7 ± 1.1 48.2 ± 1.3 38.6 ± 0.6 37.4 ± 0.6 MPH-2540 Sis Hesperis kurdica 10 
70.9 ± 1.4 55.9 ± 1.8 51.3 ± 0.6 36.1 ± 0.5 28.2 ± 1.3 22.9 ± 2.3 MPH-1835 Samsami Kelussia odoratissima 11 
52.4 ± 2.8 61.0 ± 0.6 81.9 ± 1.9 30.7 ± 1.4 35.0 ± 1.0 48.6 ± 2.1 MPH-2541 Sis Muscari longipess 12 
58.3 ± 1.2 45.3 ± 1.7 48.2 ± 1.2 25.0 ± 1.8 19.7 ± 1.2 17.4 ± 0.5 MPH-2542 Sis Nepeta heliotripochya 13 
50.6 ± 0.4 60.2 ± 0.8 57.8 ± 2.6 23.1 ± 0.9 29.1 ± 0.4 19.0 ± 1.5 MPH-2543 Sis Nonnea anchusoldes 14 
70.3 ± 1.6 59.4 ± 1.3 70.2 ± 0.8 34.8 ± 0.7 32.3 ± 0.8 37.8 ± 2.2 MPH-2544 Sis Onosma microcarpum 15 
79.2 ± 0.5 68.7 ± 2.1 61.8 ± 0.7 41.4 ± 1.2 36.5 ± 0.6 29.2 ± 1.6 MPH-2545 Sis Ornithogalum brachystachys 16 
72.4 ± 1.8 64.2 ± 0.6 40.4 ± 1.3 35.3 ± 1.6 37.2 ± 0.9 15.3 ± 0.6 MPH-2546 Sis Papaver commutatum 17 
81.9 ± 1.2 72.1 ± 0.9 48.0 ± 1.5 41.9 ± 1.3 49.1 ± 0.8 34.1 ± 1.2 MPH-2547 Zirab Parietaria judaica 18 
60.2 ± 1.4 85.2 ± 0.9 55.1 ± 1.2 42.2 ± 0.3 58.0 ± 0.7 27.3 ± 2.4 MPH-2548 Darake Plumbago europaea 19 
59.6 ± 0.6 81.4 ± 0.7 86.6 ± 1.8 23.2 ± 1.9 63.8 ± 1.3 75.6 ± 2.8 MPH-2549 Tochal Prangos  ferulacea 20 
75.1 ± 2.6 69.4 ± 1.6 63.1 ± 0.8 35.2 ± 0.7 41.4 ± 1.5 28.2 ± 3.1 MPH-2550 Velenjak Pulicaria gnaphalodes 21 
57.3 ± 0.4 62.1 ± 1.2 67.7 ± 2.8 23.6 ± 1.4 32.5 ± 1.3 30.5 ± 0.9 MPH-1220 Tekab Salvia urmiensis 22 
49.4 ± 1.7 45.3 ± 2.4 42.1 ± 1.2 15.4 ± 0.9 12.8 ± 0.4 13.1 ± 2.1 MPH-2551 Sis Scutellaria pinnatifida 23 
62.2 ± 1.2 51.9 ± 1.5 49.3 ± 0.6 34.1 ± 1.3 22.3 ± 0.7 24.6 ± 1.7 MPH-2552 Sis Sorzonera latifolia 24 
63.8 ± 0.4 73.4 ± 1.0  78.7 ± 1.8 48.9 ± 1.0 52.1 ± 1.4 39.3 ± 2.5 MPH-2553 Taleghan Vincetoxicum funebre 25 
a Data are expressed as mean ± standard deviation (n = 3). 
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Table 2. Acetylcholinesterase inhibitory activity of 
the purified compounds and concentrated fractions 
sample IC50 (µg/mL) a 
F10f 25.2 ± 0.9 
F10b 34.9 ± 1.3 
F8 38.2 ± 1.1 
Compound (2) 56.8 ± 2.5 
Compound (1) 65.1 ± 1.7 
Compound (5) 130.3 ± 3.8 
Galantamine 1.4 ± 0.1 
a Data are expressed as mean ± standard deviation (n = 3). 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Table 3. Molecular docking analysis of identified compounds from P. 
ferulaceae against the AChE enzyme 
Comp. Docking score 
(KJ/mol) 
Comp. Docking score 
(KJ/mol) 
1 -7.122 10 -7.608 
2 -8.465 11 -7.944 
3 -8.29 12 -9.317 
4 -7.555 13 -8.779 
5 -7.486 14 -9.098 
6 -6.027 15 -10.398 
7 -6.265 16 -8.582 
8 -6.483 17 -10.901 
9 -7.086 Galantamine -9.406 
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